Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis [shULK3 HKCs]

ABSTRACT: Transcriptomic profiling of three strains of primary human keratinocytes infected with two ULK3 silencing lentivirus versus control virus

ORGANISM(S): Homo sapiens

PROVIDER: GSE183084 | GEO | 2022/10/10

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis [shULK3 SCC13]

Project description:Transcriptomic profiling of human squamous cell carcinoma cells SCC13 infected with three ULK3 silencing lentivirus versus control virus

2022-10-10 | GSE183085 | GEO

The ULK3 kinase is a key determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome

Project description:Epigenetic mechanisms oversee epidermal homeostasis and oncogenesis. The identification of kinases controlling these processes has direct therapeutic implications. We show that ULK3 is a nuclear kinase with elevated expression levels in squamous cell carcinomas (SCCs) arising in multiple body sites, including skin and Head/Neck. ULK3 loss by gene silencing or deletion reduces proliferation and clonogenicity of human keratinocytes and SCC-derived cells and affects transcription impinging on stem cell-related and metabolism programs. Mechanistically, ULK3 directly binds and regulates the activity of two histone arginine methyltransferases, PRMT1 and PRMT5 (PRMT1/5), with ULK3 loss compromising PRMT1/5 chromatin association to specific genes and overall methylation of histone H4, a shared target of these enzymes. These findings are of translational significance, as downmodulating ULK3 by RNA interference or locked antisense nucleic acids (LNAs) blunts the proliferation and tumorigenic potential of SCC cells and promotes differentiation in two orthotopic models of skin cancer.

2022-11-14 | MTBLS5155 | MetaboLights

ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis

Project description:ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis

| PRJNA759135 | ENA

ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis [shULK3 SCC13]

Project description:ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis [shULK3 SCC13]

| PRJNA759139 | ENA

ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis [shULK3 HKCs]

Project description:ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis [shULK3 HKCs]

| PRJNA759140 | ENA

ULK3 is a key determinant of the keratinocyte self-renewal and tumorigenesis

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-10-10 | GSE183086 | GEO

The ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome.

| S-EPMC9935893 | biostudies-literature

Higher self renewal and oncogenic potential of keratinocytes from Black versus White populations linked to the hydroxysteroid dehydrogenase HSD17B7 gene

Project description:Transcriptomic profiling of 54 foreskin-derived human primary keratinocytes from individuals of Black African versus Caucasian ancestries.

2021-05-12 | GSE156011 | GEO

Erythropoietin promotes breast tumorigenesis through tumor initiating cell self-renewal

Project description:The erythropoietin (EPO) hormone induces red blood cell production and its recombinant form is the most prescribed drug for the treatment of anemia, including that arising in cancer patients. Based on randomized trials showing that EPO administration to cancer patients result in a decreased survival, we investigated the impact of EPO modulation on tumorigenesis. Using genetically engineered mouse models of breast cancer we found that EPO promoted tumorigenesis by activating JAK/STAT signaling specifically in breast tumor initiating cells (TICs) and promoting their self-renewal. Moreover, we define an active role for endogenous EPO in breast cancer progression and breast TIC self-renewal and demonstrate a potential application of EPO pathway inhibition in breast cancer therapy. reference x sample

| S-ECPF-GEOD-51433 | biostudies-other

Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

Project description:Erythropoietin (EPO) is a hormone that induces red blood cell production. In its recombinant form, EPO is the one of most prescribed drugs to treat anemia, including that arising in cancer patients. In randomized trials, EPO administration to cancer patients has been associated with decreased survival. Here, we investigated the impact of EPO modulation on tumorigenesis. Using genetically engineered mouse models of breast cancer, we found that EPO promoted tumorigenesis by activating JAK/STAT signaling in breast tumor-initiating cells (TICs) and promoted TIC self renewal. We determined that EPO was induced by hypoxia in breast cancer cell lines, but not in human mammary epithelial cells. Additionally, we demonstrated that high levels of endogenous EPO gene expression correlated with shortened relapse-free survival and that pharmacologic JAK2 inhibition was synergistic with chemotherapy for tumor growth inhibition in vivo. These data define an active role for endogenous EPO in breast cancer progression and breast TIC self-renewal and reveal a potential application of EPO pathway inhibition in breast cancer therapy.

| S-EPMC3904607 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data